Antidotes and reversal agents

Antidotes and reversal agents

Drug monograph · NCLEX study reference
Therapeutic class	Antidotes
Pharmacologic class	Specific reversal and detoxifying agents
Onset / peak / duration	Mostly rapid; many require repeat dosing or monitoring.
Half-life / level	Varies; titrate to clinical response.
Routes	IV
High-alert (ISMP)	No
Black box warning	Yes (see Safety)
Antidote / reversal	Not applicable (these are the antidotes).
Pregnancy / lactation	Used in emergencies.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Antidotes and reversal agents — Antidotes; Specific reversal and detoxifying agents.

Identification

• Therapeutic class: Antidotes.
• Pharmacologic class: Specific reversal and detoxifying agents.

Pharmacology

• Mechanism of action: Each counteracts a specific drug, toxin, or overdose by blocking the agent, restoring a deficient substance, binding the toxin, or providing a metabolic rescue.
• Onset / peak / duration: Mostly rapid; many require repeat dosing or monitoring.
• Half-life / therapeutic level: Varies; titrate to clinical response.

Clinical use

• Indications: Acetaminophen overdose (acetylcysteine, give early within 8 to 10 hours); opioid overdose (naloxone, repeat as it wears off); benzodiazepine overdose (flumazenil, caution, can cause seizures in dependent patients); warfarin (vitamin K plus fresh frozen plasma or prothrombin complex for urgent reversal); heparin (protamine sulfate); dabigatran (idarucizumab); factor Xa inhibitors (andexanet alfa); digoxin toxicity (digoxin immune Fab, DigiFab); iron overdose (deferoxamine); lead and heavy metals (EDTA, dimercaprol, succimer); cyanide and nitroprusside toxicity (hydroxocobalamin, sodium thiosulfate); organophosphate or cholinergic poisoning (atropine plus pralidoxime); magnesium toxicity (calcium gluconate); methotrexate toxicity (leucovorin, glucarpidase for severe cases); ethylene glycol or methanol poisoning (fomepizole); malignant hyperthermia (dantrolene); beta blocker overdose (glucagon); calcium channel blocker overdose (calcium, glucagon, high-dose insulin); anticholinergic toxicity (physostigmine); local anesthetic systemic toxicity (IV lipid emulsion); methemoglobinemia (methylene blue); neuromuscular blocker reversal (neostigmine for nondepolarizing, sugammadex for rocuronium and vecuronium).
• Usual dose, route, frequency: Per antidote protocol, usually IV in emergencies.
• Maximum dose / adjustments: Titrate to response; many need repeat dosing (especially naloxone).

Safety

• Contraindications: Agent-specific (for example, flumazenil in chronic benzodiazepine dependence or mixed overdose with seizure risk).
• Black box warning: Andexanet alfa carries a boxed warning for thromboembolic and ischemic events, cardiac arrest, and sudden death.
• Interactions: Reversal may unmask the original condition (such as pain after naloxone or re-sedation as naloxone wears off).
• Pregnancy / lactation: Used in emergencies.
• High-alert: No.

Adverse effects

• Common side effects: Withdrawal (naloxone, flumazenil), histamine release and hypotension (protamine), nausea.
• Serious effects to report: Recurrence of toxicity as the antidote wears off, allergic reaction, rebound effects.
• Antidote / reversal: Not applicable (these are the antidotes).

Nursing process

• Assessment before administration: Identify the toxin or drug, severity, vital signs, time of exposure.
• Interventions during therapy: Continue monitoring because many toxins outlast their antidote; support airway and circulation; repeat dosing as indicated; involve poison control.
• Monitor: Vital signs, level of consciousness, the specific toxidrome, repeat labs.
• Evaluation / expected outcome: Reversal of toxicity with restored function.

Patient teaching

• Patient teaching: Emergency therapy; teach take-home naloxone to at-risk patients and families.
• Notify provider if: Symptoms recur after improvement (the antidote may be wearing off).
• Administration tips: Match the antidote to the toxin; continue monitoring beyond the antidote's duration; consult poison control.